查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年亞太地區痤瘡藥物市場預測 - 區域分析 - 按治療類別、配方、類型、痤瘡類型和配銷通路
市場調查報告書
商品編碼
1567797

2030 年亞太地區痤瘡藥物市場預測 - 區域分析 - 按治療類別、配方、類型、痤瘡類型和配銷通路

Asia Pacific Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 128 Pages | 訂單完成後即時交付

價格

2022年亞太地區痤瘡藥物市場價值為1,508.26美元，預計到2030年將達到2,672.90百萬美元；預計 2023 年至 2030 年複合年成長率為 7.4%。

新藥上市推動亞太青春痘藥物市場

創新藥物的發展，包括局部和全身藥物，從根本上改變了痤瘡的治療方法。 2024 年，澳洲治療產品管理局 (TGA) 批准印度 Sun Pharmaceutical 的 Winlevi（clascoterone）乳膏 1% 用於治療 12 歲及以上個體的尋常痤瘡。 2022 年，Sun Pharmaceutical Industries 擴大了與 Cassiopea 在痤瘡治療方面的合作範圍。它已簽署了 WINLEVI（clascoterone）乳膏 1% 的許可和供應合約的延期協議，將地理範圍擴大到包括澳洲、紐西蘭、日本、巴西、墨西哥和俄羅斯。 2023 年，Torii Pharmaceutical Co., Ltd. 和 Nogra Pharma（一家臨床階段生物技術公司，為免疫發炎介導的疾病創造新型療法）宣布達成 NAC-GED-0507 的開發和商業化的外包許可協議日本治療尋常痤瘡。

新藥上市還包括具有改進功效、增強安全性和減少副作用的先進配方，滿足尋求有效痤瘡管理的個人不斷變化的需求。根據Bausch Health Companies Inc. 及其皮膚科業務Ortho Dermatologics 於2023 年10 月發布的聲明，美國食品藥物管理局(FDA) 批准了由1.2%、0.15% 和3.1 成分組成的CABTREO 外用凝膠的新藥申請分別為%克林黴素磷酸鹽、阿達帕林和過氧化苯甲醯。這是一種針對 12 歲或以上患者尋常性痤瘡的局部治療方法。 CABTREO 是 FDA 批准的第一個也是唯一一個局部三重痤瘡治療藥物，以固定劑量形式提供。該公司的目標是在 2024 年第一季向患者提供這種凝膠。

類維生素A、抗雄激素和免疫調節劑等新型藥物的引入，進一步擴大了醫療保健專業人員和痤瘡患者的治療選擇。新藥的持續推出刺激了競爭，促進了創新，並鼓勵了皮膚科製藥業的研發投資。對治療痤瘡的個人化和有針對性的治療方法的高度關注為新藥的出現奠定了基礎，以改善患者的治療結果和滿意度。因此，新藥的推出極大地促進了亞太地區痤瘡藥物市場的進步。

亞太地區痤瘡藥物市場概況

亞太地區痤瘡藥物市場分為中國、日本、印度、澳洲和韓國。預計該地區在預測期內將創下最快的複合年成長率。該地區痤瘡藥物市場的預期成長歸因於主要參與者對擴大其在發展中地區的業務的興趣日益濃厚以及護膚行業的繁榮。中國不斷成長的可支配收入增加了消費者在護膚品上的支出，從而促進了痤瘡藥物市場規模的擴大。痤瘡盛行率的增加可能與生活方式的改變和環境因素有關，這進一步刺激了對有效治療的需求。隨著中國消費者將護膚放在首位，製藥公司正在推出創新配方來滿足這一不斷成長的需求。因此，先進技術、經濟因素和不斷變化的醫療保健重點共同引導中國痤瘡藥物市場實現前所未有的成長。

亞太地區痤瘡藥物市場收入及 2030 年預測（百萬美元）

亞太地區痤瘡藥物市場細分

亞太地區痤瘡藥物市場根據治療類別、配方、類型、痤瘡類型、配銷通路和國家進行細分。

根據治療類別，亞太地區痤瘡藥物市場分為類維生素A、過氧化苯甲醯、抗生素、水楊酸等。 2022 年，類視黃醇細分市場佔據最大佔有率。

從劑型來看，亞太地區痤瘡藥物市場分為外用藥物和口服藥物。 2022 年，外用藥物領域佔據更大的佔有率。

按類型分類，亞太地區痤瘡藥物市場分為處方藥和非處方藥。 2022 年，處方藥領域佔據更大的最大佔有率。

根據痤瘡類型，亞太地區痤瘡藥物市場分為非發炎性痤瘡和發炎性痤瘡。 2022 年，發炎性痤瘡部分佔據了更大的佔有率。

就配銷通路而言，亞太痤瘡藥物市場分為藥房和藥局、零售店和電子商務。 2022 年，藥局和藥局細分市場佔據最大佔有率。

按國家/地區分類，亞太地區痤瘡藥物市場分為澳洲、中國、印度、日本、韓國和亞太地區其他地區。 2022年，中國主導亞太地區痤瘡藥物市場。

Sun Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd、Mayne Pharma Group Ltd、Almirall SA、Johnson & Johnson、Bausch Health Companies Inc、Galderma SA、Pfizer Inc、GSK Plc 和 Viatris Inc 是亞太地區營運的一些領先公司痤瘡藥物市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：亞太地區痤瘡藥物市場格局

  • PEST分析
  • 外用和口服藥物的定價分析
  • 接受痤瘡治療的患者群

第 5 章：亞太地區痤瘡藥物市場 - 主要市場動態

  • 亞太地區痤瘡藥物市場 - 主要市場動態
  • 主要市場促進因素
    • 嚴重痤瘡的盛行率不斷增加
    • 新藥上市
  • 主要市場限制
    • 與痤瘡藥物相關的副作用
  • 主要市場機會
    • 基於尖端技術和數據驅動策略的個人化治療方案
  • 未來趨勢
    • 對有機和自然療法的需求激增
  • 促進因素和限制的影響：

第 6 章：痤瘡藥物市場 - 亞太地區市場分析

第 7 章：亞太地區痤瘡藥物市場分析 - 按治療類別

  • 類維生素A
  • 過氧化苯甲醯
  • 抗生素
  • 水楊酸
  • 其他

第 8 章：亞太地區痤瘡藥物市場分析 - 按配方

  • 外用藥物
  • 口服藥物

第 9 章：亞太地區痤瘡藥物市場分析 - 按類型

  • 處方藥
  • 非處方藥

第 10 章：亞太地區痤瘡藥物市場分析 - 按痤瘡類型

  • 非發炎性痤瘡
  • 發炎性痤瘡

第 11 章：亞太地區痤瘡藥物市場分析 - 按配銷通路

  • 藥局和藥局
  • 零售店
  • 電子商務

第 12 章：亞太地區痤瘡藥物市場 - 國家分析

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區

第 13 章：痤瘡藥物市場-產業格局

  • 概述
  • 痤瘡藥物市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述
  • Farmapiel 提供的產品與其他公司痤瘡產品的比較

第 14 章：公司簡介

  • Teva Pharmaceutical Industries Ltd
  • Mayne Pharma Group Ltd
  • Almirall SA
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd
  • Bausch Health Companies Inc
  • Galderma SA
  • Pfizer Inc
  • GSK Plc
  • Viatris Inc

第 15 章：附錄

Product Code: BMIRE00030658

The Asia Pacific acne medication market was valued at US$ 1,508.26 in 2022 and is expected to reach US$ 2,672.90 million by 2030; it is estimated to register at a CAGR of 7.4% from 2023 to 2030.

Launch of Novel Drugs Boosts Asia Pacific Acne Medication Market

Innovative pharmaceutical developments, including topical and systemic medications, have fundamentally reshaped treatment approaches for acne. In 2024, the Australian Therapeutic Goods Administration (TGA) approved Winlevi (clascoterone) cream 1% from Sun Pharmaceutical of India to treat acne vulgaris in individuals 12 years of age and older. In 2022, Sun Pharmaceutical Industries broadened the scope of its collaboration with Cassiopea with respect to an acne treatment. It has signed extension agreements to the license and supply contracts for WINLEVI (clascoterone) cream 1 percent, enlarging the geographical scope to encompass Australia, New Zealand, Japan, Brazil, Mexico, and Russia. In 2023, Torii Pharmaceutical Co., Ltd. and Nogra Pharma, a clinical-stage biotechnology company creating novel therapeutics for immune-inflammatory-mediated diseases, announced an out-licensing agreement for the development and commercialization of NAC-GED-0507 for the treatment of acne vulgaris in Japan.

Novel drug launches also include advanced formulations with improved efficacy, enhanced safety profiles, and reduced side effects, catering to the evolving needs of individuals seeking effective acne management. According to a statement released in October 2023 by Bausch Health Companies Inc. and its dermatology business-Ortho Dermatologics-the US Food and Drug Administration (FDA) approved the New Drug Application for CABTREO topical gel composed of 1.2%, 0.15%, and 3.1% clindamycin phosphate, adapalene, and benzoyl peroxide, respectively. This is a topical treatment indicated for acne vulgaris in patients aged 12 or older. CABTREO is the first and only topical triple combination acne therapy approved by the FDA, which is offered in a fixed-dose form. The company aims to make this gel available for patients in Q1 2024.

The introduction of novel medications, such as retinoids, anti-androgens, and immune modulators, has further expanded the therapeutic options available for healthcare professionals and individuals dealing with acne. The continuous introduction of new drugs stimulates competition, fosters innovation, and encourages research and development investments within the dermatological pharmaceutical industry. The heightened focus on personalized and targeted treatment approaches for treating acne forms a foundation for the advent of novel drugs to improve patient outcomes and satisfaction. Thus, the launch of novel drugs significantly contributes to the progress of the Asia Pacific acne medication market.

Asia Pacific Acne Medication Market Overview

The Asia Pacific acne medication market is segmented into China, Japan, India, Australia, and South Korea. This region is expected to record the fastest CAGR during the forecast period. The projected acne medication market growth in the region is ascribed to the burgeoning interest of major players in expanding their presence in developing regions and the flourishment of the skincare industry. China's nation's rising disposable income has heightened consumer spending on skincare, contributing to the expansion of the acne medication market size. The increased prevalence of acne, possibly linked to lifestyle changes and environmental factors, has further fueled demand for effective treatments. As Chinese consumers prioritize skincare for their well-being, pharmaceutical companies are introducing innovative formulations to meet this burgeoning demand. Thus, advanced technologies, economic factors, and evolving healthcare priorities are together steering the acne medication market toward unprecedented growth in China.

Asia Pacific Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Acne Medication Market Segmentation

The Asia Pacific acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.

Based on therapeutic class, the Asia Pacific acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the Asia Pacific acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the Asia Pacific acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the Asia Pacific acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the Asia Pacific acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the Asia Pacific acne medication market is categorized into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Mayne Pharma Group Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, and Viatris Inc are some of the leading companies operating in the Asia Pacific acne medication market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Acne Medication Market Landscape

  • 4.1 PEST Analysis
  • 4.2 Pricing Analysis of Topical and Oral Medication
  • 4.3 Patient Population Undergoing Acne Treatment

5. Asia Pacific Acne Medication Market - Key Market Dynamics

  • 5.1 Asia Pacific Acne Medication Market - Key Market Dynamics
  • 5.2 Key Market Drivers
    • 5.2.1 Increasing Prevalence of Severe Acne
    • 5.2.2 Launch of Novel Drugs
  • 5.3 Key Market Restraints
    • 5.3.1 Side Effects Associated with Acne Medication
  • 5.4 Key Market Opportunities
    • 5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
  • 5.5 Future Trends
    • 5.5.1 Upsurge in Need for Organic and Natural Treatments
  • 5.6 Impact of Drivers and Restraints:

6. Acne Medication Market - Asia Pacific Market Analysis

7. Asia Pacific Acne Medication Market Analysis - by Therapeutic Class

  • 7.1 Retinoids
    • 7.1.1 Overview
    • 7.1.2 Retinoids: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Benzoyl Peroxide
    • 7.2.1 Overview
    • 7.2.2 Benzoyl Peroxide: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Antibiotics
    • 7.3.1 Overview
    • 7.3.2 Antibiotics: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Salicylic Acid
    • 7.4.1 Overview
    • 7.4.2 Salicylic Acid: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Acne Medication Market Analysis - by Formulation

  • 8.1 Topical Medication
    • 8.1.1 Overview
    • 8.1.2 Topical Medication: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Oral Medication
    • 8.2.1 Overview
    • 8.2.2 Oral Medication: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Acne Medication Market Analysis - by Type

  • 9.1 Prescription Medicine
    • 9.1.1 Overview
    • 9.1.2 Prescription Medicine: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Over-the-Counter Medicine
    • 9.2.1 Overview
    • 9.2.2 Over-the-Counter Medicine: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Acne Medication Market Analysis - by Acne Type

  • 10.1 Non-Inflammatory Acne
    • 10.1.1 Overview
    • 10.1.2 Non-Inflammatory Acne: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Inflammatory Acne
    • 10.2.1 Overview
    • 10.2.2 Inflammatory Acne: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Acne Medication Market Analysis - by Distribution Channel

  • 11.1 Pharmacies and Drug Stores
    • 11.1.1 Overview
    • 11.1.2 Pharmacies and Drug Stores: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.2 Retail Stores
    • 11.2.1 Overview
    • 11.2.2 Retail Stores: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.3 E-Commerce
    • 11.3.1 Overview
    • 11.3.2 E-Commerce: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. Asia Pacific Acne Medication Market - Country Analysis

  • 12.1 Asia Pacific
    • 12.1.1 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.2 China
      • 12.1.1.3 China: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.3.1 China: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.3.2 China: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.3.3 China: Acne Medication Market Breakdown, by Type
        • 12.1.1.3.4 China: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.3.5 China: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.4 Japan
      • 12.1.1.5 Japan: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.5.1 Japan: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.5.2 Japan: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.5.3 Japan: Acne Medication Market Breakdown, by Type
        • 12.1.1.5.4 Japan: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.5.5 Japan: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.6 India
      • 12.1.1.7 India: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.7.1 India: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.7.2 India: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.7.3 India: Acne Medication Market Breakdown, by Type
        • 12.1.1.7.4 India: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.7.5 India: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.8 Australia
      • 12.1.1.9 Australia: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.9.1 Australia: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.9.2 Australia: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.9.3 Australia: Acne Medication Market Breakdown, by Type
        • 12.1.1.9.4 Australia: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.9.5 Australia: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.10 South Korea
      • 12.1.1.11 South Korea: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.11.1 South Korea: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.11.2 South Korea: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.11.3 South Korea: Acne Medication Market Breakdown, by Type
        • 12.1.1.11.4 South Korea: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.11.5 South Korea: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.12 Rest of Asia Pacific
      • 12.1.1.13 Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.13.1 Rest of Asia Pacific: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.13.2 Rest of Asia Pacific: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.13.3 Rest of Asia Pacific: Acne Medication Market Breakdown, by Type
        • 12.1.1.13.4 Rest of Asia Pacific: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.13.5 Rest of Asia Pacific: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Acne Medication Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview
  • 13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

  • 14.1 Teva Pharmaceutical Industries Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Mayne Pharma Group Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Almirall SA
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Johnson & Johnson
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Sun Pharmaceutical Industries Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Bausch Health Companies Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Galderma SA
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Pfizer Inc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 GSK Plc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Viatris Inc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Acne Medication Market Segmentation
  • Table 2. Topical Medication
  • Table 3. Oral Medication
  • Table 4. Patient Population undergoing Acne Treatment from 2020-2023
  • Table 5. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Therapeutic Class
  • Table 6. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Formulation
  • Table 7. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 8. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Acne Type
  • Table 9. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 10. Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 11. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 12. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 13. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 14. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 15. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 16. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 17. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 18. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 19. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 20. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 21. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 22. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 23. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 24. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 25. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 26. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 27. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 28. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 29. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 30. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 31. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 32. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 33. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 34. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 35. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 36. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 37. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 38. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 39. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 40. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 41. Recent Organic Growth Strategies in Acne Medication Market
  • Table 42. Recent Inorganic Growth Strategies in the Acne Medication Market
  • Table 43. Glossary of Terms, Acne Medication Market

List Of Figures

  • Figure 1. Asia Pacific Acne Medication Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Acne Medication Market Revenue (US$ Million), 2022-2030
  • Figure 5. Asia Pacific Acne Medication Market Share (%) - by Therapeutic Class (2022 and 2030)
  • Figure 6. Retinoids: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Benzoyl Peroxide: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Antibiotics: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Salicylic Acid: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Asia Pacific Acne Medication Market Share (%) - by Formulation (2022 and 2030)
  • Figure 12. Topical Medication: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Oral Medication: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Asia Pacific Acne Medication Market Share (%) - by Type (2022 and 2030)
  • Figure 15. Prescription Medicine: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Over-the-Counter Medicine: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Asia Pacific Acne Medication Market Share (%) - by Acne Type (2022 and 2030)
  • Figure 18. Non-Inflammatory Acne: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Inflammatory Acne: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Asia Pacific Acne Medication Market Share (%) - by Distribution Channel (2022 and 2030)
  • Figure 21. Pharmacies and Drug Stores: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Retail Stores: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. E-Commerce: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Asia Pacific: Acne Medication Market - Country, 2022 (US$ Million)
  • Figure 25. Asia Pacific: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 26. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 27. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 31. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Growth Strategies in Acne Medication Market